- Home
- TPH vs VKTX Comparison
TPH vs VKTX Comparison
Compare TPH & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TPH
- VKTX
- Stock Information
- Founded
- TPH 2009
- VKTX 2012
- Country
- TPH United States
- VKTX United States
- Employees
- TPH N/A
- VKTX N/A
- Industry
- TPH Homebuilding
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- TPH Consumer Discretionary
- VKTX Health Care
- Exchange
- TPH Nasdaq
- VKTX Nasdaq
- Market Cap
- TPH 2.7B
- VKTX 2.8B
- IPO Year
- TPH N/A
- VKTX 2015
- Fundamental
- Price
- TPH $30.33
- VKTX $24.99
- Analyst Decision
- TPH Buy
- VKTX Strong Buy
- Analyst Count
- TPH 5
- VKTX 12
- Target Price
- TPH $43.00
- VKTX $89.50
- AVG Volume (30 Days)
- TPH 1.1M
- VKTX 4.6M
- Earning Date
- TPH 04-24-2025
- VKTX 04-23-2025
- Dividend Yield
- TPH N/A
- VKTX N/A
- EPS Growth
- TPH 20.35
- VKTX N/A
- EPS
- TPH 4.51
- VKTX N/A
- Revenue
- TPH $4,294,395,999.00
- VKTX N/A
- Revenue This Year
- TPH N/A
- VKTX N/A
- Revenue Next Year
- TPH $6.84
- VKTX N/A
- P/E Ratio
- TPH $6.72
- VKTX N/A
- Revenue Growth
- TPH 10.82
- VKTX N/A
- 52 Week Low
- TPH $27.90
- VKTX $18.92
- 52 Week High
- TPH $47.78
- VKTX $81.86
- Technical
- Relative Strength Index (RSI)
- TPH 46.81
- VKTX 49.24
- Support Level
- TPH $28.89
- VKTX $21.23
- Resistance Level
- TPH $32.28
- VKTX $26.95
- Average True Range (ATR)
- TPH 1.38
- VKTX 2.20
- MACD
- TPH 0.19
- VKTX 0.54
- Stochastic Oscillator
- TPH 53.41
- VKTX 74.30
About TPH Tri Pointe Homes Inc.
Tri Pointe Homes Inc is an American construction company that focuses on residential construction. The company designs and builds single-family homes and condominiums through its portfolio of six regional housing brands. Its largest regional brands include Maracay Homes, which operates in Arizona, and TRI Pointe and Pardee Homes, which operate in California, Nevada, and Colorado. From a geographic perspective, California is TRI Pointe's largest source of revenue, followed by Arizona and Nevada. The company also operates in Texas, Oregon, and Virginia. TRI Pointe completes approximately 4,000 homes annually with an average selling price around $500,000. TRI Pointe also is involved in the sale and development of land.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.